2025-03-30 16:26:39
Latest Post
IRM Energy Ltd secures 5-Year RLNG supply agreement with Gujarat State Petroleum Corporation Limited
Uno Minda Strengthens Governance, appoints Ravi Mehra as Managing Director, and Expands Board Expertise
Manoj Vaibhav Gems 'N' Jewellers Ltd opens new Jewellery store at Narsipatnam
Income Tax Authority imposes penalty of Rs. 944.20 crore on InterGlobe Aviation Limited
Tejas Networks Ltd receives Rs. 189.1657 crore under PLI scheme
Stock Report
SMS Pharmaceuticals Q3FY22 consolidated PAT at Rs. 8.96 crores
Posted On : 2022-02-09 13:51:28( TIMEZONE : IST )
SMS Pharmaceuticals Limited has reported Consolidated financial results for the period ended December 31, 2021.
Financial Results (Q3 FY2022) - QoQ Comparison
The company has reported total income of Rs. 123.3834 crores during the period ended December 31, 2021 as compared to Rs. 176.0560 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs. 8.9626 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 23.0276 crores for the period ended September 30, 2021.
The company has reported EPS of Rs. 1.07 for the period ended December 31, 2021 as compared to Rs. 2.72 for the period ended September 30, 2021.
| Financials | Q3 FY2022 | Q2 FY2022 | % Change |
| Total Income | ₹ 123.3834 crs | ₹176.0560 crs |  -29.92% |
| Net Profit | ₹8.9626 crs | ₹23.0276 crs | -61.08% |
| EPS | ₹1.07 | ₹2.72 | -60.66% |
Financial Results (Q3 FY2022) - YoY Comparison
The company has reported total income of Rs. 123.3834 crores during the period ended December 31, 2021 as compared to Rs.149.7234 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.8.9626 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.21.3935 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.1.07 for the period ended December 31, 2021 as compared to Rs.2.53 for the period ended December 31, 2020.
| Financials | Q3 FY2022 | Q3 FY2021 | % Change |
| Total Income | ₹ 123.3834 crs | ₹149.7234 crs | -17.59% |
| Net Profit | ₹8.9626 crs | ₹21.3935 crs | -58.11% |
| EPS | ₹1.07 | ₹2.53 | -57.71% |
Financial Results (9 Months Ended FY2022) - YoY Comparison
The company has reported total income of Rs.463.7266 crores during the 9 Months period ended December 31, 2021 as compared to Rs.394.0403 crores during the 9 Months period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.55.8109 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.39.3898 crores for the 9 Months period ended December 31, 2020.
The company has reported EPS of Rs.6.59 for the 9 Months period ended December 31, 2021 as compared to Rs.4.65 for the 9 Months period ended December 31, 2020.
| Financials | 9 Months Ended FY2022 | 9 Months Ended FY2021 | % Change |
| Total Income | ₹463.7266 crs | ₹394.0403 crs |  17.69% |
| Net Profit | ₹55.8109 crs | ₹39.3898 crs | 41.69% |
| EPS | ₹6.59 | ₹4.65 | 41.72% |
Shares of SMS Pharmaceuticals Limited was last trading in BSE at Rs. 127.40 as compared to the previous close of Rs. 126.90. The total number of shares traded during the day was 3786 in over 157 trades.
The stock hit an intraday high of Rs. 133.00 and intraday low of 124.05. The net turnover during the day was Rs. 482292.00.
